{"tml_elements":["Version","Citation","Compound","PureOrMixtureData"],"PureOrMixtureData":[{"tml_elements":["nPureOrMixtureDataNumber","Component","eExpPurpose","sCompiler","sContributor","dateDateAdded","Property","PhaseID","Variable","NumValues"],"PhaseID":[{"tml_elements":["ePhase"],"ePhase":"Liquid"},{"RegNum":{"tml_elements":["nOrgNum"],"nOrgNum":1},"tml_elements":["ePhase","RegNum"],"ePhase":"Crystal"}],"Component":[{"tml_elements":["RegNum","nSampleNm"],"RegNum":{"nOrgNum":1,"tml_elements":["nOrgNum"]},"nSampleNm":1},{"nSampleNm":1,"RegNum":{"nOrgNum":2,"tml_elements":["nOrgNum"]},"tml_elements":["RegNum","nSampleNm"]}],"sContributor":"TRC","Variable":[{"VariableID":{"tml_elements":["VariableType"],"VariableType":{"eTemperature":"Temperature, K","tml_elements":["eTemperature"]}},"VarPhaseID":{"tml_elements":["eVarPhase"],"eVarPhase":"Liquid"},"nVarNumber":1,"tml_elements":["nVarNumber","VariableID","VarPhaseID"]},{"VariableID":{"tml_elements":["VariableType"],"VariableType":{"tml_elements":["ePressure"],"ePressure":"Pressure, kPa"}},"tml_elements":["nVarNumber","VariableID","VarPhaseID"],"nVarNumber":2,"VarPhaseID":{"tml_elements":["eVarPhase"],"eVarPhase":"Liquid"}}],"eExpPurpose":"Principal objective of the work","Property":[{"tml_elements":["nPropNumber","Property-MethodID","PropPhaseID","ePresentation","Solvent"],"ePresentation":"Direct value, X","nPropNumber":1,"PropPhaseID":{"tml_elements":["ePropPhase"],"ePropPhase":"Liquid"},"Property-MethodID":{"tml_elements":["PropertyGroup","RegNum"],"PropertyGroup":{"tml_elements":["CompositionAtPhaseEquilibrium"],"CompositionAtPhaseEquilibrium":{"tml_elements":["ePropName","sMethodName"],"ePropName":"Amount concentration (molarity), mol/dm3","sMethodName":"?"}},"RegNum":{"tml_elements":["nOrgNum"],"nOrgNum":1}},"Solvent":{"RegNum":[{"nOrgNum":2,"tml_elements":["nOrgNum"]}],"tml_elements":["RegNum"]}}],"dateDateAdded":"3/25/2019","nPureOrMixtureDataNumber":1,"sCompiler":"VVD","NumValues":[{"tml_elements":["VariableValue","PropertyValue"],"PropertyValue":[{"nPropValue":4.06,"nPropNumber":1,"nPropDigits":3,"tml_elements":["nPropNumber","nPropValue","nPropDigits"]}],"VariableValue":[{"nVarNumber":1,"nVarDigits":4,"tml_elements":["nVarNumber","nVarValue","nVarDigits"],"nVarValue":298.2},{"nVarValue":101,"nVarNumber":2,"nVarDigits":3,"tml_elements":["nVarNumber","nVarValue","nVarDigits"]}]}]}],"THERMOML_MD5_CHECKSUM":"a24e121bd88c5c351e424ddd75f3f805","Compound":[{"Sample":[{"purity":[],"tml_elements":["nSampleNm","eStatus","purity"],"eStatus":"notDescribed","nSampleNm":1}],"tml_elements":["RegNum","sStandardInChI","sStandardInChIKey","sCommonName","sFormulaMolec","Sample"],"sCommonName":["3-pyridinecarboxamide","niacinamide","nicotinamide","nicotinic acid amide"],"sFormulaMolec":"C6H6N2O","sStandardInChI":"InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)","RegNum":{"tml_elements":["nOrgNum"],"nOrgNum":1},"sStandardInChIKey":"DFPAKSUCGFBDDF-UHFFFAOYSA-N"},{"sFormulaMolec":"H2O","Sample":[{"nSampleNm":1,"eStatus":"notDescribed","tml_elements":["nSampleNm","eStatus","purity"],"purity":[]}],"sCommonName":["water"],"tml_elements":["RegNum","sStandardInChI","sStandardInChIKey","sCommonName","sFormulaMolec","Sample"],"sStandardInChI":"InChI=1S/H2O/h1H2","RegNum":{"nOrgNum":2,"tml_elements":["nOrgNum"]},"sStandardInChIKey":"XLYOFNOQVPJJNP-UHFFFAOYSA-N"}],"Citation":{"eSourceType":"Original","TRCRefID":{"sAuthor1":"sha","sAuthor2":"vel","tml_elements":["yrYrPub","sAuthor1","sAuthor2","nAuthorn"],"nAuthorn":"0","yrYrPub":"2014"},"sAbstract":"Soly. is an important physiochem. property of pharmaceutical compds., and cocrystn. is one method used to improve the soly. of drugs.  Carbamazepine is a drug from class II, according to the biopharmaceutical classification system, and it forms a cocrystal with nicotinamide.  Carbamazepine cocrystd. with nicotinamide was synthesized using the solvent evapn. approach, and its characteristics were detd. using differential scanning calorimetry and powder X-ray diffractometry.  The soly. of various solid phases in ethanol + water mixts. was investigated at different temps. using the shake-flask method, and the resulting ppts. were characterized.  The soly. of carbamazepine was increased with the addn. of ethanol up to a mass fraction of 0.8.  Nevertheless, max. soly. of NIC is obsd. in neat solvent (water).  While the soly. of a cocrystal depends on the concn. of the coformer and its stability in the soln.","sDOI":"10.1016/j.fluid.2013.11.024","sTitle":"Solubility of carbamazepine, nicotinamide and carbamazepine-nicotinamide cocrystal in ethanol-water mixtures","tml_elements":["TRCRefID","eType","eSourceType","sAuthor","sPubName","yrPubYr","dateCit","sTitle","sAbstract","sDOI","sVol","sPage"],"sAuthor":["Shayanfar, Ali","Velaga, Sitaram","Jouyban, Abolghasem"],"sPubName":"Fluid Phase Equilib.","yrPubYr":"2014","dateCit":"2020-09-29","sPage":"97-105","sVol":"363","eType":"journal"},"Version":{"nVersionMajor":2,"nVersionMinor":0,"tml_elements":["nVersionMajor","nVersionMinor"]}}